BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37233453)

  • 1. Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro.
    Xia X; Wang Y; Shao Y; Xu J; Liang B; Liu W; Zeng J; Li C; Guan H; Wang S; Xing D
    Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma.
    Peng J; Zhao J; Zhao Y; Wu P; Gou L; Fu S; Chen P; Lu Y; Yang L
    Int J Nanomedicine; 2020; 15():6409-6420. PubMed ID: 32922008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
    Xia X; Zhou X
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.
    Ramesh J; Thilakan RC; Gopalakrishnan RM; Vijayapoopathi S; Dorschel A; Venugopal B
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
    Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
    J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel synergistic anticancer effect of fungal cholestanol glucoside and paclitaxel: Apoptosis induced by an intrinsic pathway through ROS generation in cervical cancer cell line (HeLa).
    Subramaniam Y; Subban K; Chelliah J
    Toxicol In Vitro; 2021 Apr; 72():105079. PubMed ID: 33422634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
    Wang J
    Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
    Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
    Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.
    Yu Y; Xu S; You H; Zhang Y; Yang B; Sun X; Yang L; Chen Y; Fu S; Wu J
    Drug Deliv; 2017 Nov; 24(1):75-82. PubMed ID: 28155566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of paclitaxel-loaded and folic acid-modified poly (lactic-co-glycolic acid) nano-micelles and in vitro anticancer effect on cervical cancer HeLa cells].
    Li XJ; You Y; Zhang QL; Zhang BB; Yan L; Ou ZM; Zhang Y; Wang YJ; Tong Y; Liu DW; Wang JY
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2481-2488. PubMed ID: 34047094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
    Li J; Chen L; Liu Q; Tang M; Wang Y; Yu J
    Cancer Biol Ther; 2018 Jun; 19(6):507-517. PubMed ID: 29400636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
    Qiu H; Li J; Liu Q; Tang M; Wang Y
    Cell Cycle; 2018; 17(10):1235-1244. PubMed ID: 29886786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.
    Dong M; Li P; Xie Y; Wang Z; Wang R
    Drug Dev Res; 2021 Dec; 82(8):1193-1205. PubMed ID: 34046939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.
    Hernandez-Flores G; Ortiz-Lazareno PC; Lerma-Diaz JM; Dominguez-Rodriguez JR; Jave-Suarez LF; Aguilar-Lemarroy Adel C; de Celis-Carrillo R; del Toro-Arreola S; Castellanos-Esparza YC; Bravo-Cuellar A
    BMC Cancer; 2011 Nov; 11():483. PubMed ID: 22074157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
    Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
    Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
    Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
    Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
    Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
    Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
    Du G; Cao D; Meng L
    Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.